U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040501) titled 'Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI' on June 06.
Brief Summary: The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
DEVICE: Chat GPT
On the date of appointment, participants will be given up to 30 minutes, to interact with a pre-prompted Chat GPT (Prostate Pathology Guide) using a Cleveland clinic device.
Recruitment Status: NOT_YET_RECRUITING
Sponsor...